Related references
Note: Only part of the references are listed.Renieramycin T Inhibits Melanoma B16F10 Cell Metastasis and Invasion via Regulating Nrf2 and STAT3 Signaling Pathways
Baohua Yu et al.
MOLECULES (2022)
STAT3 activation in HER2-positive breast cancers: Analysis of data from a large prospective trial
Amir Sonnenblick et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Interaction of Nrf2 with dimeric STAT3 induces IL-23 expression: Implications for breast cancer progression
Su-Jung Kim et al.
CANCER LETTERS (2021)
The intricacies of NRF2 regulation in cancer
Cody J. Schmidlin et al.
SEMINARS IN CANCER BIOLOGY (2021)
Targeting NRF2 to treat cancer
Jared Sivinski et al.
SEMINARS IN CANCER BIOLOGY (2021)
LL1, a novel and highly selective STAT3 inhibitor, displays anti-colorectal cancer activities in vitro and in vivo
Zhe Liu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression
Kaitao Yuan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Soluble receptor for advanced glycation end-products promotes angiogenesis through activation of STAT3 in myocardial ischemia/reperfusion injury
Xianxian Cao et al.
APOPTOSIS (2020)
Down-regulated microRNA-195-5p and up-regulated CXCR4 attenuates the heart function injury of heart failure mice via inactivating JAK/STAT pathway
Yuhua Shen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
The autophagy-independent role of BECN1 in colorectal cancer metastasis through regulating STAT3 signaling pathway activation
Fuqing Hu et al.
CELL DEATH & DISEASE (2020)
A STAT3 of Addiction: Adipose Tissue, Adipocytokine Signalling and STAT3 as Mediators of Metabolic Remodelling in the Tumour Microenvironment
Rose Kadye et al.
CELLS (2020)
Small extracellular vesicles secreted by human iPSC-derived MSC enhance angiogenesis through inhibiting STAT3-dependent autophagy in ischemic stroke
Yuguo Xia et al.
STEM CELL RESEARCH & THERAPY (2020)
Modulating NRF2 in Disease: Timing Is Everything
Matthew Dodson et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)
The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin
Qiang Liu et al.
CELL BIOLOGY INTERNATIONAL (2019)
Identification of Nrf2/STAT3 axis in induction of apoptosis through sub-G1 cell cycle arrest mechanism in HT-29 colon cancer cells
Issa Tajmohammadi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Enhanced p62-NRF2 Feedback Loop due to Impaired Autophagic Flux Contributes to Arsenic-Induced Malignant Transformation of Human Keratinocytes
Xiafang Wu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
BBI608 inhibits cancer sternness and reverses cisplatin resistance in NSCLC
Lauren MacDonagh et al.
CANCER LETTERS (2018)
Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development
Jacopo Sgrignani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
THE KEAP1-NRF2 SYSTEM: A THIOL-BASED SENSOR-EFFECTOR APPARATUS FOR MAINTAINING REDOX HOMEOSTASIS
Masayuki Yamamoto et al.
PHYSIOLOGICAL REVIEWS (2018)
STAT3: The art of multi-tasking of metabolic and immune functions in obesity
Wei Hu et al.
PROGRESS IN LIPID RESEARCH (2018)
Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation
Kouhei Tsuchida et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
被撤回的出版物: Nuclear factor erythroid 2-related factor 2 enhances carcinogenesis by suppressing apoptosis and promoting autophagy in nickel-transformed cells (Retracted article. See vol. 293, pg. 15457, 2018)
Young-Ok Son et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Remote Limb Ischaemic Postconditioning Protects Against Myocardial Ischaemia/Reperfusion Injury in Mice: Activation of JAK/STAT3-Mediated Nrf2-Antioxidant Signalling
Sumin Gao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells
Yuan Seng Wu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
Targeting JAK kinase in solid tumors: emerging opportunities and challenges
M. Buchert et al.
ONCOGENE (2016)
Cancer Stem Cells: Basic Concepts and Therapeutic Implications
Dany Nassar et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)
Signal transducer and activator of transcription 3: a year in review
Lisa R. Forbes et al.
CURRENT OPINION IN HEMATOLOGY (2016)
Targeting transcription factor STAT3 for cancer prevention and therapy
Edna Zhi Pei Chai et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells
Seung Ho Baek et al.
PHYTOMEDICINE (2016)
Ginkgetin Blocks Constitutive STAT3 Activation and Induces Apoptosis through Induction of SHP-1 and PTEN Tyrosine Phosphatases
Seung Ho Baek et al.
PHYTOTHERAPY RESEARCH (2016)
The emerging role of signal transducer and activator of transcription 3 in cerebral ischemic and hemorrhagic stroke
Zhenxing Liang et al.
PROGRESS IN NEUROBIOLOGY (2016)
Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism
Chengguang Zhao et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition
Hong Liu et al.
CARCINOGENESIS (2015)
p62/SQSTM1 functions as a signaling hub and an autophagy adaptor
Yoshinori Katsuragi et al.
FEBS JOURNAL (2015)
Structural and functional characterization of Nrf2 degradation by glycogen synthase kinase 3/β-TrCP
Antonio Cuadrado
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease
Lauren E. Tebay et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling
Peng Zhang et al.
GYNECOLOGIC ONCOLOGY (2015)
Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma
Cheolhee Won et al.
HEPATOLOGY (2015)
Impact of the N-Terminal Domain of STAT3 in STAT3-Dependent Transcriptional Activity
Tiancen Hu et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3
Xiaoyun Dai et al.
MOLECULAR ONCOLOGY (2015)
Review of STAT3 (Signal Transducers and Activators of Transcription) in head and neck cancer
Shrikant Balasaheb Mali
ORAL ONCOLOGY (2015)
Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis
Beatrice Grabner et al.
NATURE COMMUNICATIONS (2015)
NF-κB signaling in cancer stem cells: a promising therapeutic target?
K. Vazquez-Santillan et al.
CELLULAR ONCOLOGY (2015)
Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel
Jong Hyun Lee et al.
ONCOTARGET (2015)
VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2
D. Zhao et al.
ONCOGENE (2015)
Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis
Tongde Wu et al.
GENES & DEVELOPMENT (2014)
Development of a Novel Azaspirane That Targets the Janus Kinase-Signal Transducer and Activator of Transcription (STAT) Pathway in Hepatocellular Carcinoma in Vitro and in Vivo
Chakrabhavi Dhananjaya Mohan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Tackling the cancer stem cells - what challenges do they pose?
Diwakar R. Pattabiraman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention
Ailian Xiong et al.
CANCERS (2014)
RXRα Inhibits the NRF2-ARE Signaling Pathway through a Direct Interaction with the Neh7 Domain of NRF2
Hongyan Wang et al.
CANCER RESEARCH (2013)
The emerging role of the Nrf2-Keap1 signaling pathway in cancer
Melba C. Jaramillo et al.
GENES & DEVELOPMENT (2013)
Arsenic Inhibits Autophagic Flux, Activating the Nrf2-Keap1 Pathway in a p62-Dependent Manner
Alexandria Lau et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Autophagy in Human Health and Disease REPLY
Augustine M. K. Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
IL-26 Promotes the Proliferation and Survival of Human Gastric Cancer Cells by Regulating the Balance of STAT1 and STAT3 Activation
Wei You et al.
PLOS ONE (2013)
STAT3 suppresses transcription of proapoptotic genes in cancer cells with the involvement of its N-terminal domain
Olga A. Timofeeva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
MECHANISMS OF DISEASE Autophagy in Human Health and Disease
Augustine M. K. Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Autophagy as a Stress-Response and Quality-Control Mechanism: Implications for Cell Injury and Human Disease
Lyndsay Murrow et al.
Annual Review of Pathology-Mechanisms of Disease (2012)
Signal Transducer and Activator of Transcription 3 (STAT3) Protein Suppresses Adenoma-to-carcinoma Transition in Apcmin/+ Mice via Regulation of Snail-1 (SNAI) Protein Stability
Jongdae Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Structural and Functional Characterization of Nrf2 Degradation by the Glycogen Synthase Kinase 3/β-TrCP Axis
Patricia Rada et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
The cytoprotective role of the Keap1-Nrf2 pathway
Liam Baird et al.
ARCHIVES OF TOXICOLOGY (2011)
Nrf2: control of sensitivity to carcinogens
Stephen L. Slocum et al.
ARCHIVES OF TOXICOLOGY (2011)
Autophagy inhibition engages Nrf2-p62 Ub-associated signaling
Brigit E. Riley et al.
AUTOPHAGY (2011)
Enhanced sensitivity of A549 cells to the cytotoxic action of anticancer drugs via suppression of Nrf2 by procyanidins from Cinnamomi Cortex extract
Tomokazu Ohnuma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots
Hasan Korkaya et al.
CLINICAL CANCER RESEARCH (2011)
Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
Hongting Zheng et al.
DIABETES (2011)
Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs
Xiuwen Tang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy?
Claire Villalva et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Hypoxia-inducible Factor-1α Enhances Haptoglobin Gene Expression by Improving Binding of STAT3 to the Promoter
Mi-Kyung Oh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells
Yoshihiro Inami et al.
JOURNAL OF CELL BIOLOGY (2011)
IL-6 Promotes Head and Neck Tumor Metastasis by Inducing Epithelial-Mesenchymal Transition via the JAK-STAT3-SNAIL Signaling Pathway
Arti Yadav et al.
MOLECULAR CANCER RESEARCH (2011)
Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
Dongmei Ren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung
Hironori Satoh et al.
CARCINOGENESIS (2010)
p62/SQSTM1 Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription
Ashish Jain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction between Keap1 and p62
Alexandria Lau et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1
Masaaki Komatsu et al.
NATURE CELL BIOLOGY (2010)
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
Adam Wu et al.
NEURO-ONCOLOGY (2010)
Activated STAT3 Regulates Hypoxia-Induced Angiogenesis and Cell Migration in Human Glioblastoma
Shin-Hyuk Kang et al.
NEUROSURGERY (2010)
Increased cell migration and plasticity in Nrf2-deficient cancer cell lines
G. Rachakonda et al.
ONCOGENE (2010)
Regulation of the IL-23 and IL-12 Balance by Stat3 Signaling in the Tumor Microenvironment
Marcin Kortylewski et al.
CANCER CELL (2009)
STAT3 Regulation of Glioblastoma Pathogenesis
Nuria la Iglesia et al.
CURRENT MOLECULAR MEDICINE (2009)
Direct Interaction between Nrf2 and p21Cip1/WAF1 Upregulates the Nrf2-Mediated Antioxidant Response
Weimin Chen et al.
MOLECULAR CELL (2009)
Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells
N. J. Sullivan et al.
ONCOGENE (2009)
The Increasing Complexity of the Cancer Stem Cell Paradigm
Jeffrey M. Rosen et al.
SCIENCE (2009)
Altered Disposition of Acetaminophen in Nrf2-null and Keap1-knockdown Mice
Scott A. Reisman et al.
TOXICOLOGICAL SCIENCES (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Protein tyrosine phosphatases in the JAK/STAT pathway
Dan Xu et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway
Nuria de la Iglesia et al.
GENES & DEVELOPMENT (2008)
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
Pingyan Cheng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Dual roles of Nrf2 in cancer
Alexandria Lau et al.
PHARMACOLOGICAL RESEARCH (2008)
Activation of Nrf2 by arsenite and monomethylarsonous acid is independent of Keap1-C151: enhanced Keap1-Cul3 interaction
Xiao-Jun Wang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Sites of alkylation of human Keap1 by natural Chemoprevention agents
Yan Luo et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2007)
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas
Sizhi Paul Gao et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Identification of the highly reactive cysteine 151 in the chemopreventive agent-sensor Keap1 protein is method-dependent
Aimee L. Eggler et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2007)
Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2
Zheng Sun et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NF kappa B
Jinbo Yang et al.
GENES & DEVELOPMENT (2007)
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Hua Yu et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Structure, function, and regulation of STAT proteins
Cheh Peng Lim et al.
MOLECULAR BIOSYSTEMS (2006)
Role of STAT3 in type I interferon responses - Negative regulation of STAT1-dependent inflammatory gene activation
Hao H. Ho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: Enhanced expression in psoriatic skin
G Piskin et al.
JOURNAL OF IMMUNOLOGY (2006)
The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation
P Nioi et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema
T Iizuka et al.
GENES TO CELLS (2005)
Stem-like cells in bone sarcomas: Implications for tumorigenesis
CP Gibbs et al.
NEOPLASIA (2005)
Role of Stat3 in regulating p53 expression and function
GL Niu et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Stat3 in resident macrophages inflammatory response
A Matsukawa et al.
JOURNAL OF IMMUNOLOGY (2005)
Regulation of gene-activation pathways by pias proteins in the immune system
K Shuai et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Modifying specific cysteines of the electrophile-sensing human Keap1 disrupt binding to the protein is insufficient to Nrf2 domain Neh2
AL Eggler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells
A Saudemont et al.
BLOOD (2005)
Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis
K Iida et al.
CANCER RESEARCH (2004)
Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron
M McMahon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The molecular basis of pluripotency in mouse embryonic stem cells
I Chambers
CLONING AND STEM CELLS (2004)
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
TH Wang et al.
NATURE MEDICINE (2004)
Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles
K Itoh et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia
M Tartaglia et al.
NATURE GENETICS (2003)
Basement membranes: Structure, assembly and role in tumour angiogenesis
R Kalluri
NATURE REVIEWS CANCER (2003)
Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells
I Chambers et al.
CELL (2003)
The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells
K Mitsui et al.
CELL (2003)
Interactive effects of nrf2 genotype and oltipraz on benzo[a]pyrene-DNA adducts and tumor yield in mice
M Ramos-Gomez et al.
CARCINOGENESIS (2003)
Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway
M Kanai et al.
ONCOGENE (2003)
Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress
DD Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells
S Sun et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription
Y Katoh et al.
GENES TO CELLS (2001)
Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice
M Ramos-Gomez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
G Bergers et al.
NATURE CELL BIOLOGY (2000)
Share Paper
